Greetings. It's Friday, June the 14th, 2024. Welcome to the Daily Article podcast. Today's

article is written by Dr. Ryan Dennison and narrated by Chris Elkins of the Denison Forum.

Note, in the wake of the Southern Baptist Convention's resolution regarding the use of

in vitro fertilization,

we have received numerous questions and concerns about how to understand that decision.

Dr. Jim Denison will be addressing this subject in Monday's daily article, but for more on what

the Bible says on the subject and how we should approach it, please find a link in today's

episode notes to his article on

in vitro fertilization from earlier this year. On Thursday, the Supreme Court ruled unanimously

against a challenge that would make it difficult for people to receive the abortion drug

Mepheprestone. The case was brought before the nation's highest court in response to a ruling

last year where a U.S.

District Judge in Texas decided that the Food and Drug Administration did not properly account

for the additional risks and side effects caused by changes to how the drug was prescribed and

administered. But before we get into what that decision means and where it might lead, let's start

by talking a bit more about Mepheprestone and why this case was so important. Mepheprestone is the

first of two pills typically prescribed to women looking to end their pregnancy. It blocks progesterone,

a hormone that, among other things, helps create a suitable environment for the child to grow and develop during pregnancy.

As a result, the embryo stops growing and is then aborted when a second drug called Mesopostol is taken a day or two later.

In the wake of the Roe v. Wade reversal, the combination is now responsible conservatively for more than half of all abortions in the

United States and about three quarters of the abortions in Europe. As such, the case had the

potential to make significant changes to the abortion landscape around the country. But while their

...